CAVA Add to watchlist $88.44 +0.26 (+0.29%) Last updated: Apr 16, 2026 05:00
52-Week Range
$88.44
$43.41 $88.44 $101.50

Fundamentals Overview

CAVA Group, Inc. is near the high of its 52-week range with premium valuation, trading relatively flat today.

Valuation premium

P/E 163.7 P/B 13.16 P/S 8.72

Profitability

Net margin 5.4%

Risk (Beta)

2.04 — higher vol

Earnings & growth

EPS $0.54 Rev -5.9% Profit -66.6% vs prior qtr

BullzEye Analysis

Our composite tilts Hold on technicals (e.g. RSI, ADX, trend), fundamentals, sentiment, sector and index context, and risk.

Composite Signal

Sell
Buy
Hold — 55% confidence Risk: High Volatility — Beta 2.04. Consider smaller position size due to higher beta.

Supporting (Buy):

3M vs S&P 500: +24.4% · 3M vs Consumer Cyclical sector: +30.2%

Pressures (Sell):

Sentiment weakening (1 downgrade) · Beta 2.04 (elevated)

Not financial advice. For education and research only; do your own research and consider a financial advisor before investing.

Key Stats

Market Cap
$10.29B
P/E (TTM)
163.74
EPS (TTM)
$0.54
Dividend Yield
N/A
52-Week Range
$43.41 - $101.50
Volume vs Avg
N/A
Beta
2.04

About

CAVA Group, Inc. owns and operates a chain of Mediterranean restaurants. The company offers salads, dips, spreads, toppings, and dressings. It sells its products through whole food markets and grocery stores. The company also provides online food ordering services. Cava Group, Inc. was founded in 2006 and is based in Washington, District of Columbia.
Sector: Consumer Cyclical
Headquarters: US
Employees: 10,300
IPO Date: Jun 2023
Website: www.cava.com
Beta: 2.04 (More volatile than market)

Ratings & Grades at a Glance

Overall rating: C+. Recent institutional grades: majority downgrades. Current institutional positions: Buy: 7, Equal Weight: 4, Hold: 1, Neutral: 10, Outperform: 6, Overweight: 2.

Financial story & AI narrative

Open this tab to load the financial story.

Valuation & Ratios

Valuation, liquidity, and profitability metrics are consolidated here (including ratios that previously appeared in the Financials story). Trailing (TTM) vs forward-looking (e.g. DCF) is noted on each line where it matters.

DCF vs price: DCF estimate is $-14.49; current price is $88.44. That’s a -116.4% gap. When the gap is large (e.g. >20%), that’s divergence; when they’re close, that’s convergence. Differences can reflect growth expectations, sector premiums, or conservative vs. optimistic assumptions. Use DCF as one input alongside technicals and sentiment.

Metric Value
Valuation
P/E (TTM) 163.74
PEG (TTM) N/A
P/B (TTM) 13.16
P/S (TTM) 8.72
P/FCF (TTM) 393.73
Liquidity & enterprise
Current Ratio (TTM) 1.74
Quick Ratio (TTM) 1.74
Cash Ratio (TTM) 1.74
Profitability
ROE (TTM) N/A
ROA (TTM) N/A
Revenue growth (YoY) N/A
Net margin (TTM) 5.4%
Gross margin (TTM) 18.38%
Operating margin (TTM) 6.73%
Debt to equity (TTM) N/A

Latest News

News loads when you open this tab.

Price Target, Ratings & Grades

Analyst price targets, consensus, rating snapshot, and institutional grades for CAVA.

Analyst Sentiment at a Glance

C+ Sentiment Weakening
Buy 7Equal Weight 4Hold 1Neutral 10Outperform 6Overweight 2
0 upgrades, 1 downgrade
Price Target Consensus
Current $88.44
Median $77.50
Consensus $79.36
Low consensus $52.00
High consensus $133.00

Stock Grades (Institutions)

Institution Action Previous Grade New Grade Date
Goldman Sachs maintain Neutral Neutral 2026-04-13
Mizuho maintain Neutral Neutral 2026-04-02
TD Cowen maintain Buy Buy 2026-04-02
Keybanc maintain Overweight Overweight 2026-03-03
Argus Research downgrade Buy Hold 2026-02-27
Morgan Stanley maintain Equal Weight Equal Weight 2026-02-25
Telsey Advisory Group maintain Outperform Outperform 2026-02-25
Truist Securities maintain Buy Buy 2026-02-25
TD Cowen maintain Buy Buy 2026-02-25
Bernstein maintain Outperform Outperform 2026-02-25
Citigroup maintain Neutral Neutral 2026-02-25
Piper Sandler maintain Overweight Overweight 2026-02-25
RBC Capital maintain Outperform Outperform 2026-02-25
UBS maintain Neutral Neutral 2026-02-25
Truist Securities maintain Buy Buy 2026-02-23
Telsey Advisory Group maintain Outperform Outperform 2026-02-19
UBS maintain Neutral Neutral 2026-02-18
Citigroup maintain Neutral Neutral 2026-02-12
Morgan Stanley maintain Equal Weight Equal Weight 2026-01-20
Mizuho maintain Neutral Neutral 2026-01-09
Truist Securities maintain Buy Buy 2026-01-08
Barclays maintain Equal Weight Equal Weight 2026-01-07
UBS maintain Neutral Neutral 2026-01-06
Bernstein maintain Outperform Outperform 2026-01-05
Argus Research maintain Buy Buy 2025-11-13
Bernstein maintain Outperform Outperform 2025-11-05
Citigroup maintain Neutral Neutral 2025-11-05
Stifel maintain Buy Buy 2025-11-05
UBS maintain Neutral Neutral 2025-11-05
Barclays maintain Equal Weight Equal Weight 2025-11-05